Roche pays US$2.4 billion for rest of cancer expert Foundation Medicine
Swiss drugmaker Roche Holding AG has agreed to pay US$137 per share to buy the rest of Foundation Medicine (FMI) , a US$2.4 billion transaction that values the U.S. genomic profiling group at US$5.3 billion, the partners said on Tuesday.
Valve Software doesn’t just distribute games and make digital hats. It also tracks how its Steam members interact with their software. Over the last several years, the company has looked at which controllers and gamepads players have connected to their PCs. Using that data, the company has some insights. For example, Steam has 783 registered […]